IMA Advisory Services’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$167K Hold
1,116
0.01% 345
2026
Q1
$103K Hold
1,116
0.01% 208
2025
Q4
$114K Hold
1,116
0.01% 200
2025
Q3
$69.7K Sell
1,116
-196
-15% -$10.7K 0.01% 219
2025
Q2
$68.3K Sell
1,312
-90
-6% -$4.02K 0.01% 211
2025
Q1
$59.7K Sell
1,402
-14,246
-91% -$615K 0.01% 219
2024
Q4
$478K Sell
15,648
-476
-3% -$13.4K 0.06% 146
2024
Q3
$370K Buy
16,124
+370
+2% +$10.5K 0.08% 124
2024
Q2
$455K Sell
15,754
-216
-1% -$5.03K 0.2% 68
2024
Q1
$329K Sell
15,970
-1,235
-7% -$26.5K 0.16% 69
2023
Q4
$465K Sell
17,205
-13,897
-45% -$365K 0.23% 61
2023
Q3
$922K Sell
31,102
-248
-0.8% -$8.72K 0.24% 94
2023
Q2
$1.12M Buy
31,350
+2,110
+7% +$60.6K 0.29% 92
2023
Q1
$685K Buy
+29,240
New +$835K 0.18% 104

Other funds holding GH

IMA Advisory Services's GH Position: Q2 2026 in Review

IMA Advisory Services held its Guardant Health (GH) position steady in Q2 2026 at 1,116 shares worth $167K. The position accounts for 0.01% of the portfolio, ranked #345.

IMA Advisory Services first reported a position in GH in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.12M in Q2 2023. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • IMA Advisory Services held 1,116 shares of Guardant Health worth $167K as of Q2 2026.
  • IMA Advisory Services left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up 0.01% of IMA Advisory Services's portfolio in Q2 2026, its #345 holding.
  • IMA Advisory Services first reported a position in Guardant Health in Q1 2023 and has held it in 14 quarters since.
  • IMA Advisory Services's Guardant Health position peaked at $1.12M in Q2 2023.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.